Georges J L, Livarek B, Gibault-Genty G, Messaoudi H, Aziza J P, Hautecoeur J L, Soleille H
Service de cardiologie, centre hospitalier de Versailles, hôpital André-Mignot, Le Chesnay.
Arch Mal Coeur Vaiss. 2007 Mar;100(3):175-81.
X-ray exposure of patient during coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA) may have some deleterious effects. The dose area product (DAP), related to the effective dose, is a measure of stochastic risk and a potential quality indicator. The aim of our study was to assess radiation exposure of patients in a large series of "real life" interventional cardiac procedures. We evaluated DAP and Fluoroscopy time (t) during CA and/or PTCA in 3600 consecutive patients from 2002 to 2005. Procedures were performed by five experienced physicians, using successively femoral and radial techniques. DAP and t significantly correlated (r = 0.73; p < 0.0001). Median [25th-75th percentiles] values for DAP and for t were 63 [40-101] Gy.cm2 and 6.3 [4-10] min for CA, 100 [62-178] Gy.cm2 and 14.0 [9-22] min for elective PTCA, and 141 [90-219] Gy.cm2 and 15.7 [11-23] min for CA immediately followed by ad hoc PTCA, respectively. Differences between operators ranged from 50% (CA) to 70% (PTCA) for both DAP and t (p < 0.001). Moving from the femoral to the radial approach resulted in a 1.5 to 2-fold increase in DAP in 2002 (p < 0.001). DAP and t then decreased toward the european DIMOND reference values (in 2005: 53.4 Gy.cm2 and 5.5 min for CA, 104.64 Gy.cm2 and 13.1 min for elective PTCA, 128.4 Gy.cm2 and 13.6 min for ad hoc PTCA). In conclusion, radiation exposure to patients and staff are strongly dependent on operators, time course, and the arterial access, due in part to the learning curve for radial approach. The enhanced knowledge of radiation dose is the first step of a radiation dose-reduction program, likely to minimize patient and operator radiation hazards in interventional cardiology. Definition of national reference values for DAP and fluoroscopy time would be helpful for appropriate comparisons.
在冠状动脉造影(CA)和经皮腔内冠状动脉成形术(PTCA)期间对患者进行X线照射可能会产生一些有害影响。与有效剂量相关的剂量面积乘积(DAP)是随机风险的一种度量,也是一个潜在的质量指标。我们研究的目的是评估大量“真实生活”中的心脏介入手术患者的辐射暴露情况。我们评估了2002年至2005年连续3600例患者在CA和/或PTCA期间的DAP和透视时间(t)。手术由五位经验丰富的医生进行,先后采用股动脉和桡动脉技术。DAP和t显著相关(r = 0.73;p < 0.0001)。CA的DAP和t的中位数[第25 - 75百分位数]分别为63 [40 - 101] Gy·cm²和6.3 [4 - 10]分钟,择期PTCA为100 [62 - 178] Gy·cm²和14.0 [9 - 22]分钟,CA后立即进行急诊PTCA为141 [90 - 219] Gy·cm²和15.7 [11 - 23]分钟。DAP和t在不同操作者之间的差异范围为50%(CA)至70%(PTCA)(p < 0.001)。2002年从股动脉途径改为桡动脉途径导致DAP增加了1.5至2倍(p < 0.001)。随后DAP和t朝着欧洲DIMOND参考值下降(2005年:CA为53.4 Gy·cm²和5.5分钟;择期PTCA为104.64 Gy·cm²和13.1分钟;急诊PTCA为128.4 Gy·cm²和13.6分钟)。总之,患者和工作人员的辐射暴露在很大程度上取决于操作者、时间进程和动脉入路,部分原因是桡动脉途径的学习曲线。增强对辐射剂量的认识是辐射剂量降低计划的第一步,这可能会使介入心脏病学中患者和操作者的辐射危害降至最低。定义DAP和透视时间的国家参考值将有助于进行适当的比较。